Latest on generative AI, model launches, enterprise rollouts, and AI policy shifts worldwide.
Nine thousand six hundred chips in one pod. One hundred and twenty-one exaflops in a single training cluster. Google TPU 8 debuted at Cloud Next 2026 on April 22, splitting into two purpose-built dies — TPU 8t for training and TPU 8i for inference — in the first such bifurcation across a decade of TPU silicon. Read more »
Ninety-nine percent text accuracy. That’s the number that tore through the last line designers counted on. OpenAI unveiled ChatGPT Images 2.0 in a livestream on April 21, 2026, and in a single prompt the model now handles the UI screenshots, infographics, manga, and slide decks human designers used to own. Read more »
$30 billion. Four months ago, that number belonged to OpenAI alone. On April 7, 2026, Anthropic revenue on an annualized run-rate basis (ARR, a standard SaaS gauge that multiplies monthly revenue by twelve) crossed $30B — and the company became the first AI startup to pass the chief rival that dominated the sector for three straight years. Read more »
Google is negotiating a Gemini Pentagon classified AI deal 2026 that would place its frontier model inside the Department of War’s secret networks. The Information reported on April 16 that the talks cover the classified tier of a program known as GenAI.mil. Bloomberg Law, Ground News, and Business Today independently relayed the same reporting within 48 hours. Read more »
46,225 square millimeters. That is roughly the size of a dinner plate. It is also the die area of Cerebras Systems’ WSE-3 (Wafer-Scale Engine 3), a single AI chip 57 times larger than NVIDIA’s flagship B200 GPU. Read more »
One billion dollars. That was the price tag on OpenAI’s licensing deal with Disney. In April 2026, OpenAI walked away from it — all for a model codenamed GPT-5.5 ‘Spud.’ Read more »
One hundred percent. That was the success rate when Physical Intelligence’s latest robot brain attempted tasks it had never been trained on — zero relevant data, zero prior demonstrations on the target hardware. Read more »
Drug discovery just entered a new era. On April 14, 2026, Danish pharmaceutical giant Novo Nordisk — the maker of Ozempic and Wegovy — announced a sweeping partnership with OpenAI to embed artificial intelligence agents across its entire operational chain. From genomic data analysis to supply chain optimization, every stage of how a drug is found, made, and delivered is now on the table. Read more »
“What’s the difference between an AI agent and a chatbot?” It is now the most common question in product meetings across the enterprise stack. Add LLM to the mix and the confusion doubles. Read more »
Seventy-four percent. That is the share of AI’s total economic value flowing to just one-fifth of global companies — the starkest measure yet of the AI divide. PwC’s 2026 AI Performance Study, released on April 13, surveyed 1,217 senior executives at director level and above across 25 sectors and multiple regions, evaluating 60 discrete AI management and investment practices. Read more »